Expert Opinion on Investigational Drugs

JournalCitation impact & published research

Expert Opinion on Investigational Drugs is a journal indexed in ScholarIQ from OpenAlex. ScholarIQ records 5,116 works, 136,231 citations and an h-index of 132.

5,116

Works

136,231

Citations

132

h-index

IDs:OpenAlex

What are the most-cited papers on Expert Opinion on Investigational Drugs?

ScholarIQmost cited works

Vandetanib (ZD6474): an orally available receptor tyrosine kinase inhibitor that selectively targets pathways critical for tumor growth and angiogenesis

Roy S. Herbst, John V. Heymach, Michael S. O’Reilly, Amir Onn, Anderson J. Ryan

Expert Opinion on Investigational Drugs. 2007144 Citations

Neuropharmacology and potential efficacy of new treatments for tobacco dependence

Karl Fagerström, David J.K. Balfour

Expert Opinion on Investigational Drugs. 200697 Citations

Update on treatment for idiopathic hypersomnia

Elisa Evangelista, Régis Lopez, Yves Dauvilliers

Expert Opinion on Investigational Drugs. 201733 Citations

Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis

Rossella Siligato, Valeria Cernaro, Chiara Nardi, Francesca Gregorio, Guido Gembillo, Giuseppe Costantino, Giovanni Conti, Michele Buemi, Domenico Santoro

Expert Opinion on Investigational Drugs. 201821 Citations

Ciprofloxacin DPI in non-cystic fibrosis bronchiectasis: a Phase II randomized study

Sabina A Antoniu, Doina Azoicăi

Expert Opinion on Investigational Drugs. 201318 Citations